The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-β
- 30 September 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 130 (1-2) , 194-201
- https://doi.org/10.1016/s0165-5728(02)00215-1
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Genetic basis for clinical expression in multiple sclerosisBrain, 2002
- Evidence of Linkage with HLA-DR in DRB1*15-Negative Families with Multiple SclerosisAmerican Journal of Human Genetics, 2001
- Interferon-β treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-γ and interleukin-4Journal of Neuroimmunology, 2000
- A Test for Linkage and Association in General Pedigrees: The Pedigree Disequilibrium TestAmerican Journal of Human Genetics, 2000
- Prevalence of Multiple Sclerosis in the Sanitary District of Calatayud, Northern Spain: Is Spain a Zone of High Risk for this Disease?Neuroepidemiology, 1998
- Defining the clinical course of multiple sclerosisNeurology, 1996
- Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 allelesHuman Immunology, 1994
- HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosisHuman Immunology, 1991
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983